Yang Qian, Feng Maohui, Ma Xiang, Li Huachi, Xie Wei
Department of Ultrasound, Hubei Cancer Hospital, Wuhan, Hubei 430071, P.R. China.
Department of Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, P.R. China.
Oncol Lett. 2017 Nov;14(5):6071-6078. doi: 10.3892/ol.2017.6915. Epub 2017 Sep 8.
The present study aimed to compare gene expression profiles between colorectal cancer and adjacent normal tissues, and to perform a preliminarily analysis of the key genes and underlying molecular mechanisms implicated in colorectal cancer development. Gene expression microarray chips were used to screen genes that were differently expressed between colorectal cancer and adjacent normal tissues. Approximately 1,183 genes were differentially expressed in cancer tissues compared with adjacent normal tissues (P≤0.05; fold difference, >2.0), of which 570 genes were upregulated and 613 genes were downregulated. In total, 6 upregulated genes, including keratin 23, collagen type X α1, collagen type XI α1, cell migration-inducing hyaluronan-binding protein, transforming growth factor-β1 and V-Myc avian myelocytomatosis viral oncogene homolog, and 2 downregulated genes, including channel α subunit 7 and EPH receptor A7, were selected and validated using reverse transcription-quantitative polymerase chain reaction, which exhibited results that were consistent with the microarray analysis. These 1,183 differentially expressed genes were further classified into 71 groups based on their functions using gene ontology and pathway analyses. Kyoto Encyclopedia of Genes and Genomes analysis of these upregulated or downregulated genes suggested that 23 signaling pathways were involved. The present study preliminarily screened for and identified key genes and signaling pathways that may be closely associated with colorectal cancer development. However, subsequent gene function studies are required to verify these findings.
本研究旨在比较结直肠癌组织与癌旁正常组织之间的基因表达谱,并对参与结直肠癌发生发展的关键基因及潜在分子机制进行初步分析。采用基因表达微阵列芯片筛选结直肠癌组织与癌旁正常组织中差异表达的基因。与癌旁正常组织相比,癌组织中约有1183个基因差异表达(P≤0.05;差异倍数>2.0),其中570个基因上调,613个基因下调。总共选取了6个上调基因,包括角蛋白23、X型胶原α1、XI型胶原α1、细胞迁移诱导透明质酸结合蛋白、转化生长因子-β1和V-Myc禽骨髓细胞瘤病毒癌基因同源物,以及2个下调基因,包括通道α亚基7和EPH受体A7,并使用逆转录定量聚合酶链反应进行验证,结果与微阵列分析一致。利用基因本体论和通路分析,根据其功能将这1183个差异表达基因进一步分为71组。对这些上调或下调基因进行京都基因与基因组百科全书分析表明,涉及23条信号通路。本研究初步筛选并鉴定了可能与结直肠癌发生发展密切相关的关键基因和信号通路。然而,后续需要进行基因功能研究以验证这些发现。